EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Dupilumab in the Treatment of Keloids
- Status
- COMPLETED
- Phase
- PHASE4
Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
- Status
- COMPLETED
- Phase
- PHASE4
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women
- Status
- COMPLETED
- Phase
- PHASE1
MInimal Residual Disease Adapted Strategy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
- Status
- RECRUITING
- Phase
- N/A
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
- Status
- COMPLETED
- Phase
- N/A
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4